CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net loss	$ (541)	$ (1,446)
Depreciation and amortization	200	280
Stock-based compensation expense	188	233
Gain on equity method investment	(101)	0
Other non-cash activities	20	203
Changes in operating assets and liabilities:
Accounts receivable, net	31	(228)
Inventory	(364)	(435)
Other assets	14	(81)
Accounts payable and accrued liabilities	334	113
Deferred revenue	59	32
Other liabilities	(28)	60
Net cash used in operating activities	(188)	(1,269)
Cash flows from investing activities:
Purchases of short-term investments	(835)	(902)
Sales of short-term investments	48	0
Maturities of short-term investments	717	550
Capital expenditures	(338)	(254)
Net cash used in investing activities	(408)	(606)
Cash flows from financing activities:
Proceeds from issuance of capital stock including employee stock purchase plan	3	2
Other financing activities	(9)	(4)
Net cash used in financing activities	(6)	(2)
Effect of exchange rate changes on cash and cash equivalents	1	(1)
Net change in cash	(601)	(1,878)
Cash, cash equivalents, and restricted cash—Beginning of period	5,294	7,857
Cash, cash equivalents, and restricted cash—End of period	4,693	5,979
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	423	383
Capital stock issued to settle bonuses	47	179
Right-of-use assets obtained in exchange for operating lease liabilities	$ 73	$ 52